Company news
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) news
Maravai LifeSciences Holdings, Inc. news releases on 6ix. Latest, Jan 5, 2022: Maravai LifeSciences Announces Registration and Webcast Information…
Press releases — page 3
Maravai LifeSciences Announces Registration and Webcast Information for Upcoming R&D Day, to be Held on January 28, 2022
January 4, 2022
Maravai LifeSciences Added to the Nasdaq Biotechnology Index
December 13, 2021
Maravai LifeSciences Announces Establishment of New Charitable Foundation
December 8, 2021
Maravai LifeSciences Reports Third Quarter Financial Results, Updates 2021 Financial Guidance and Provides Preliminary Revenue Guidance For 2022
November 9, 2021
Maravai LifeSciences Announces November 2021 Investor Conference Schedule
November 1, 2021
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 10, 2021
October 12, 2021
Maravai LifeSciences Expands its Intellectual Property Portfolio with European Patent
October 6, 2021
TriLink BioTechnologies® Extends EyeGene Partnership for COVID-19 Vaccine Development in South Korea
October 3, 2021
Maravai LifeSciences Announces Pricing of Secondary Offering of Class A Common Stock by Selling Stockholders
September 9, 2021
Maravai LifeSciences Announces September 2021 Investor Conference Schedule
September 6, 2021
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
September 6, 2021
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
August 9, 2021
TriLink BioTechnologies® Extends Global Support of Covid-19 Vaccine Development into APAC Region with the Chula Vaccine Research Center (Chula VRC), Bangkok
August 1, 2021
Codex DNA Announces Licensing and Supply Deal with TriLink Biotechnologies for CleanCap® mRNA Capping Technology
July 20, 2021
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, August 10, 2021
July 19, 2021
Maravai LifeSciences Announces June 2021 Investor Conference Schedule
May 25, 2021
Maravai Lifesciences Reports First Quarter Financial Results and Updates 2021 Financial Guidance
May 9, 2021
Maravai LifeSciences Announces Investor Conference Schedule for the Month of May 2021
May 4, 2021
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 10, 2021
April 12, 2021
Maravai LifeSciences Announces Closing of Secondary Offering of Class A Common Stock by Selling Stockholders and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
April 11, 2021
Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A Common Stock by Selling Stockholders
April 6, 2021
Maravai LifeSciences Announces Preliminary Unaudited First Quarter Revenues and Income From Operations Range
April 4, 2021
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common Stock by Selling Stockholders
April 4, 2021
Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink BioTechnologies' Plasmid DNA Manufacturing Services
March 14, 2021
Maravai LifeSciences Reports Fourth Quarter and Full Year 2020 Financial Results and Initiates 2021 Financial Guidance
March 1, 2021
Maravai LifeSciences Announces March 2021 Investor Conference Schedule
February 28, 2021
Maravai LifeSciences Expands Its Intellectual Property Portfolio
February 9, 2021
Maravai LifeSciences To Host Earnings Conference Call on Tuesday, March 2, 2021
January 27, 2021
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
November 23, 2020
Maravai LifeSciences Announces Pricing of an Upsized Initial Public Offering
November 18, 2020